Jack Bendheim has sold PAHC and made no open-market buys since Jan 2016
President, CEO and 10% owner at Phibro Animal Health Corporation
SEC CIK 0001241560 · Filings on SEC.gov ↗
Every filing
55 filings since Jan 2016, newest first
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
Phibro Animal Health Corp
President, CEO and 10% owner
About Jack Bendheim
Jack C. Bendheim (age 78) is the Chairman, President, and Chief Executive Officer of Phibro Animal Health Corporation (PAHC), a role he has held in various capacities since joining the company in 1969.( His career at PAHC includes serving as Vice President & Treasurer (1975–1983), Executive Vice President & Treasurer (1983–1988), Chief Operating Officer (1988–1998), and CEO from 1998–2002 and again since March 2014, while acting as a director since 1984 and President since 1988.( Bendheim controls significant voting power (approx. 90.9%) through BFI Co., LLC, which he manages, making PAHC a controlled company under Nasdaq rules; he is the largest individual shareholder with over 53% ownership.(
Bendheim has held external roles such as President of HealthforAnimals (since March 2025), past Chairman of the Animal Health Institute, and former Director of Empire Resources, Inc.( A planned leadership transition announced in December 2025 will see him resign as CEO and President effective July 1, 2026, transitioning to Executive Chairman while his son, Daniel (Dani) Bendheim, assumes those roles.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.